Clinical characteristics of middle-aged and older patients with MS treated with interferon beta-1b: post-hoc analysis of a 2-year, prospective, international, observational study

BACKGROUND: Despite trends towards the increased age of patients living with multiple sclerosis (MS), little is known about the response of older adults with MS to disease-modifying therapies (DMTs). Thus, a post-hoc analysis was undertaken using data from a 2-year, international, non-interventional...

Descripción completa

Detalles Bibliográficos
Autores principales: Patti, Francesco, Penaherrera, Javier Nicolas, Zieger, Lorissa, Wicklein, Eva-Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381478/
https://www.ncbi.nlm.nih.gov/pubmed/34425763
http://dx.doi.org/10.1186/s12883-021-02347-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381478/
https://www.ncbi.nlm.nih.gov/pubmed/34425763
http://dx.doi.org/10.1186/s12883-021-02347-w

Ejemplares similares